2016
DOI: 10.1016/j.tranon.2016.08.003
|View full text |Cite
|
Sign up to set email alerts
|

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer

Abstract: Tumors have exceptionally high demands for energy and anabolism because of their rapid growth. The de novo serine synthesis pathway initiated by phosphoglycerate dehydrogenase (PHGDH) has been recognized as a hallmark of metabolic adaption in carcinogenesis. The oncogenic role and prognostic value of PHGDH have been investigated in multiple cancer types, including breast cancer, melanoma, cervical cancer, and colon cancer. Due to the importance of PHGDH in cancer, we attempted to determine the clinical signifi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
48
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(48 citation statements)
references
References 34 publications
0
48
0
Order By: Relevance
“…SNP rs72699833 is located on chromosome 1 and is associated in cis with PHGDH, a gene involved in the metabolism of serine that is overexpressed in some subtypes of breast, cervical, colorectal and non-small-cell lung cancer, and in these diseases generally associated with a poorer outcome. [37][38][39][40] In addition, rs72699833 is associated through our eQTL analysis in trans with five other genes: LAD1 on chromosome 1, COL17A1 on chromosome 10, KRT10 on chromosome 17, LGALS7B on chromosome 19 and FERMT1 on chromosome 20 (Supplementary Table S8). All of these genes are involved in epithelium development and in particular with extracellular matrix (ECM) secretion and cell-ECM interactions.…”
Section: Cancer-risk Snps Regulate Cancer-related Biological Functionsmentioning
confidence: 94%
“…SNP rs72699833 is located on chromosome 1 and is associated in cis with PHGDH, a gene involved in the metabolism of serine that is overexpressed in some subtypes of breast, cervical, colorectal and non-small-cell lung cancer, and in these diseases generally associated with a poorer outcome. [37][38][39][40] In addition, rs72699833 is associated through our eQTL analysis in trans with five other genes: LAD1 on chromosome 1, COL17A1 on chromosome 10, KRT10 on chromosome 17, LGALS7B on chromosome 19 and FERMT1 on chromosome 20 (Supplementary Table S8). All of these genes are involved in epithelium development and in particular with extracellular matrix (ECM) secretion and cell-ECM interactions.…”
Section: Cancer-risk Snps Regulate Cancer-related Biological Functionsmentioning
confidence: 94%
“…Then, the signal was amplified and visualized with diaminobenzidine-chromogen, followed by counterstaining with hematoxylin. TLR4, inflammation cytokines and ECM protein immunostaining were analyzed using intensity and distribution measurements as previously described (55,56) and the staining intensity was determined as follows: 0, no staining; 1, weak; 2, moderate and 3, strong. The staining distribution was determined as the percentage of positive cells (0, none; 1, <25%; 2, 25-75%; and 3, 75-100%).…”
Section: Genementioning
confidence: 99%
“…The signal was amplified and visualized with diaminobenzidine-chromogen, followed by counterstaining with hematoxylin. Nampt immunostaining was analyzed using intensity and distribution measurements as previously described [47][48][49]. The staining intensity was scored as 0 (no staining), 1 (weak), 2 (moderate), and 3 (strong).…”
Section: Immunohistochemistry (Ihc)mentioning
confidence: 99%